Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes

European Journal of Endocrinology

Volumn 170, Issue 4, 2014, Pages 539-545

  Dzygało, Katarzyna ^a   Szypowska, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ASPART; INSULIN GLULISINE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF MONITORING;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ASPART; MALE; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84899488361     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0696     Document Type: Article

References (24)

1. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S & Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001 24 1858-1862. (doi:10.2337/diacare.24. 11.1858)
2. Nilsson A, Radeborg K & Bjorck I. Effects on cognitive performance of modulating the postprandial blood glucose profile at breakfast. European Journal of Clinical Nutrition 2012 66 1039-1043. (doi:10.1038/ejcn. 2012.80)
3. Danne T, Becker RH, Heise T, Bittner C, Frick AD & Rave K. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 2005 28 2100-2105. (doi:10.2337/diacare.28.9.2100)
4. Heise T, Nosek L, Spitzer H, Heinemann L, Niemoeller E, Frick AD & Becker RHA. Insulin glulisine: a faster onset of action compared with insulin lispro. Diabetes, Obesity & Metabolism 2007 9 746-753. (doi:10.1111/j.1463- 1326.2007.00746.x)
5. Arnolds S, Rave K, Hovelmann U, Fischer A, Sert-Langeron C & Heise T. Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers. Experimental and Clinical Endocrinology & Diabetes 2010 118 662-664. (doi:10.1055/s-0030-1252067)
6. Morrow L, Muchmore DB, Hompesch M, Ludington EA & Vaughn DE. Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase. Diabetes Care 2013 36 273-275. (doi:10.2337/dc12-0808)
7. Kawamori R, Kadowaki T, Ishii H, Iwasaki M & Iwamoto Y. Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus. Diabetes, Obesity & Metabolism 2009 11 891-899. (doi:10.1111/j.1463-1326. 2009.01086.x)
8. Dreyer M, Prager R, Robinson A, Busch K, Ellis G, Souhami E & Van Leendert R. Efficacy and safety of insulin glulisine in patients with type 1 diabetes. Hormone and Metabolic Research 2005 37 702-707. (doi:10.1055/s-2005- 870584)
9. Hoogma RP & Schumicki D. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Hormone and Metabolic Research 2006 38 429-433. (doi:10.1055/s-2006- 944549)
10. Philotheou A, Arslanian S, Blatniczky L, Peterkova V, Souhami E & Danne T. Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes. Diabetes Technology & Therapeutics 2011 13 327-334. (doi:10.1089/dia.2010.0072)
11. Cemeroglu AP, Kleis L, Wood A, Parkes C, Wood MA & Davis AT. Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections. Endocrine Practice 2013 19 614-619. (doi:10.4158/EP12399. OR)
12. Schulz KF, Altman DG & Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010 340 c332. (doi:10.1136/bmj.c332)
13. Clarke W, Jones T, Rewers A, Dunger D & Klingensmith GJ. ISPAD clinical practice consensus guidelines 2009 compendium. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes 2009 10 (Suppl 12) 134-144. (doi:10.1111/j.1399-5448.2009.00583.x)
14. Le Floch JP, Escuyer P, Baudin E, Baudon D & Perlemuter L. Blood glucose area under the curve. Methodological aspects. Diabetes Care 1990 13 172-175. (doi:10.2337/diacare.13.2.172)
15. Van Bon AC, Bode BW, Sert-Langeron C, De Vries JH & Charpentier G. Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technology & Therapeutics 2011 13 607-614. (doi:10.1089/dia.2010.0224)
16. Nilsson M, Stenberg M, Frid AH, Holst JJ & Bjorck IM. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. American Journal of Clinical Nutrition 2004 80 1246-1253.
17. Rabasa-Lhoret R, Garon J, Langelier H, Poisson D & Chiasson JL. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralenteregular) insulin regimen. Diabetes Care 1999 22 667-673. (doi:10.2337/diacare.22.5.667)
18. Franz MJ. The glycemic index: not the most effective nutrition therapy intervention. Diabetes Care 2003 26 2466-2468. (doi:10.2337/diacare. 26.8.2466)
19. Szypowska A, Pankowska E & Lipka M. Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion. Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego 2006 12 45-50.
20. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P & Klingensmith GJ. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes 2009 10 (Suppl 12) 71-81. (doi:10.1111/j.1399-5448. 2009.00582.x)
21. Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L & Riccardi G. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 2000 23 1461-1466. (doi:10.2337/diacare.23.10.1461)
22. Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P & Werther GA. The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 2001 24 1137-1143. (doi:10.2337/diacare.24.7.1137)
23. Niwano Y, Adachi T, Kashimura J, Sakata T, Sasaki H, Sekine K, Yamamoto S, Yonekubo A & Kimura S. Is glycemic index of food a feasible predictor of appetite, hunger, and satiety? Journal of Nutritional Science and Vitaminology 2009 55 201-207. (doi:10.3177/jnsv. 55.201)
24. Kilpatrick ES, Rigby AS & Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009 32 1901-1903. (doi:10.2337/dc09-0109)